Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Janus kinase 2 | 0.385 | 0.885 | 0.65 |
|
disease | 1.000 | None | 0.968 | 327 | 5 | 2005 | 2020 | ||||||||
|
MPL proto-oncogene, thrombopoietin receptor | 0.510 | 0.692 | 4.1E-09 |
|
disease | 1.000 | None | 0.978 | 86 | 3 | 1995 | 2020 | ||||||||
|
calreticulin | 0.413 | 0.923 | 0.89 |
|
disease | 0.800 | limited | 0.929 | 97 | 0 | 2013 | 2020 | ||||||||
|
tet methylcytosine dioxygenase 2 | 0.458 | 0.808 | 4.3E-54 |
|
disease | 0.500 | None | 0.909 | 10 | 0 | 2009 | 2019 | ||||||||
|
enhancer of zeste 2 polycomb repressive complex 2 subunit | 0.376 | 0.885 | 1.00 |
|
disease | 0.350 | None | 1.000 | 5 | 1 | 2010 | 2019 | ||||||||
|
GATA binding protein 1 | 0.483 | 0.808 | 0.95 |
|
disease | 0.290 | None | 1.000 | 9 | 0 | 2001 | 2020 | ||||||||
|
MYB proto-oncogene, transcription factor | 0.490 | 0.692 | 0.82 |
|
disease | 0.220 | None | 1.000 | 2 | 0 | 2007 | 2015 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.150 | None | 1.000 | 5 | 4 | 2008 | 2019 | ||||||||
|
neurobeachin like 2 | 0.617 | 0.769 | 6.0E-02 |
|
disease | 0.120 | None | 1.000 | 2 | 0 | 2014 | 2019 | ||||||||
|
megakaryocyte and platelet inhibitory receptor G6b | 0.695 | 0.500 | 1.1E-06 |
|
disease | 0.120 | None | 1.000 | 2 | 0 | 2018 | 2018 | ||||||||
|
ABL proto-oncogene 1, non-receptor tyrosine kinase | 0.432 | 0.923 | 1.00 |
|
disease | 0.100 | None | 1.000 | 41 | 0 | 1995 | 2019 | ||||||||
|
Janus kinase 1 | 0.474 | 0.769 | 1.00 |
|
disease | 0.100 | None | 0.976 | 41 | 0 | 2012 | 2020 | ||||||||
|
CD34 molecule | 0.368 | 0.808 | 5.0E-06 |
|
disease | 0.100 | None | 1.000 | 27 | 0 | 1993 | 2019 | ||||||||
|
BCR activator of RhoGEF and GTPase | 0.431 | 0.885 | 0.99 |
|
disease | 0.100 | None | 1.000 | 26 | 0 | 1992 | 2019 | ||||||||
|
ASXL transcriptional regulator 1 | 0.482 | 0.808 | 1.3E-14 |
|
disease | 0.100 | None | 0.957 | 23 | 0 | 2011 | 2019 | ||||||||
|
thrombopoietin | 0.513 | 0.692 | 0.20 |
|
disease | 0.100 | None | 1.000 | 16 | 0 | 1997 | 2020 | ||||||||
|
sterol O-acyltransferase 1 | 0.424 | 0.846 | 7.4E-10 |
|
disease | 0.100 | None | 1.000 | 15 | 0 | 2007 | 2019 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
disease | 0.100 | None | 1.000 | 12 | 0 | 2002 | 2018 | ||||||||
|
serine and arginine rich splicing factor 2 | 0.561 | 0.731 | 0.48 |
|
disease | 0.100 | None | 0.900 | 10 | 0 | 2012 | 2019 | ||||||||
|
signal transducer and activator of transcription 5A | 0.445 | 0.808 | 1.00 |
|
disease | 0.100 | None | 0.900 | 10 | 0 | 2007 | 2019 | ||||||||
|
signal transducer and activator of transcription 5B | 0.442 | 0.808 | 1.00 |
|
disease | 0.090 | None | 0.889 | 9 | 0 | 2007 | 2019 | ||||||||
|
isocitrate dehydrogenase (NADP(+)) 1 | 0.424 | 0.808 | 2.6E-12 |
|
disease | 0.080 | None | 0.875 | 8 | 1 | 2010 | 2018 | ||||||||
|
isocitrate dehydrogenase (NADP(+)) 2 | 0.434 | 0.808 | 0.88 |
|
disease | 0.070 | None | 0.857 | 7 | 2 | 2010 | 2017 | ||||||||
|
CD177 molecule | 0.595 | 0.654 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 2002 | 2012 | |||||||||
|
C-X-C motif chemokine receptor 4 | 0.362 | 0.923 | 1.8E-02 |
|
disease | 0.070 | None | 0.857 | 6 | 0 | 2007 | 2015 |